Skip to main content
PMC home page
Journal of Clinical and Experimental Hepatology logoLink to Journal of Clinical and Experimental Hepatology
. 2012 Apr 12;2(1):55–69. doi: 10.1016/S0973-6883(12)60088-7

Gluing Gastric Varices in 2012: Lessons Learnt Over 25 Years

Vivek A Saraswat *,*, Abhai Verma †
PMCID: PMC3940364  PMID: 25755406

Abstract

Bleeding from gastric varices (GV) continues to pose a challenge to the endoscopist and no consensus has been reached on the best way for treating these patients. Gastric variceal obturation (GVO) with the tissue adhesive, N-2-butyl-cyanoacrylate (NBC), is considered the treatment of first-choice for this condition in most parts of the world. The liquid monomer polymerizes into a solid cast, obturating the vessel within 10–20 s of coming in contact with ionic solutions such as blood. Gastric variceal obturation achieves hemostasis in over 90% of patients with active bleeding, eradicates GV in over 80% of these patients, and re-bleeding occurs in 3–30%. These results are comparable with those of transjugular intrahepatic portosystemic shunting (TIPS; over 90% hemostasis in acute bleeding with re-bleeding in 15–30%). Though, there has been no direct comparison with GVO, balloon-occluded retrograde transvenous obliteration of GV (BRTO) achieves near 100% obliteration with recurrence in 0–10% and is superior to TIPS for hemostasis in active bleeding when used in combination with transcatheter sclerotherapy. Several complications have been described for GVO including thromboembolic complications which occur in 0.5–4.3% and may be devastating in some. Many of the complications and the variability in results of GVO can be attributed to variations in injection technique. The use of a standardized injection technique has been reported to achieve 100% hemostasis and obliteration with 6.9% re-bleeding and no embolic complications. Gastric variceal obturation with NBC continues to be the first-choice therapy for GV bleeding outside Japan. Adherence to a standard injection technique will maximize hemostasis and eradication of GV while minimizing complications of therapy.

Keywords: BRTO, gastric varices, glue injection, GVO, NBC, pulmonary embolism

Abbreviations: BRTO, balloon-occluded retrograde transvenous obliteration; EUS, endoscopic ultrasound; EV, esophageal varices; GV, gastric varices; GVO, gastric variceal obturation; MCA, methyl-2-cyanoacrylate; NBC, N-2-butyl-cyanoacrylate; OCA, 2-octylcyanoacrylate; TIPS, transjugular intrahepatic portosystemic shunting

Full Text

The Full Text of this article is available as a PDF (254.8 KB).

References

  • 1.Coover HN, Joyner FB, Sheerer NH. Chemistry and performance of cyanoacrylate adhesive. Special Technical Papers. 1959;5:413–417. [Google Scholar]
  • 2.Hayes, Sharon Caskey. Discovery of Super Glue helped land Coover in National Inventors Hall of Fame. Kingsport Times-News, July 11, 2004.
  • 3.Rees, Jasper. The end of our Kodak moment. London: The Telegraph, January 20, 2012.
  • 4.Vinters HV, Galil KA, Lundie MJ. The histotoxicity of cyanoacrylates. A selective review. Neuroradiology. 1985;27:279–291. doi: 10.1007/BF00339559. [DOI] [PubMed] [Google Scholar]
  • 5.Galil KA, Schofield ID, Wright GZ. Effect of n-butyl-2-cyanoacrylate (histoacryl blue) on the healing of skin wounds. J Can Dent Assoc. 1984;50:565–569. [PubMed] [Google Scholar]
  • 6.Kosko PI. Upper lid blepharoplasty: skin closure achieved with butyl-2-cyanoacrylate. Ophthalmic Surg. 1981;12:424–425. [PubMed] [Google Scholar]
  • 7.Ellis RA, Levin AM. Experimental sutureless ocular surgery. Am J Ophthalmol. 1963;55:733. [Google Scholar]
  • 8.Moschos M, Droutsas D, Boussalis P. Clinical experience with cyanoacrylate tissue adhesive. Documenta Ophthalmologica. 1997;93:237–245. doi: 10.1007/BF02569064. [DOI] [PubMed] [Google Scholar]
  • 9.Duvvi SK, Lo S, Kumar R. Superglue (Cyanoacrylate) in the Nose. Otolaryngol Head Neck Surg. 2005;133:803–804. doi: 10.1016/j.otohns.2004.09.090. [DOI] [PubMed] [Google Scholar]
  • 10.Soehendra N, Nam VC, Grimm H. Endoscopic obliteration of large esophago-gastric varices with bucrylate. Endoscopy. 1986;18:25–26. doi: 10.1055/s-2007-1013014. [DOI] [PubMed] [Google Scholar]
  • 11.Soehendra N, Grimm H, Nam VC. 10 years' experience with endoscopic sclerotherapy of esophagogastric varices. Chirurgie. 1989;60:594–598. [PubMed] [Google Scholar]
  • 12.Garcia-Tsao G, Sanyal AJ, Grace ND. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938. doi: 10.1002/hep.21907. [DOI] [PubMed] [Google Scholar]
  • 13.de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176. doi: 10.1016/j.jhep.2005.05.009. [DOI] [PubMed] [Google Scholar]
  • 14.Mahadeva S, Bellamy MC, Kessel D. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688–2693. doi: 10.1111/j.1572-0241.2003.08769.x. [DOI] [PubMed] [Google Scholar]
  • 15.Sarin SK, Mishra SR. Endoscopic therapy for gastric varices. Clin Liv Dis. 2010;14:263–279. doi: 10.1016/j.cld.2010.03.007. [DOI] [PubMed] [Google Scholar]
  • 16.Thalheimer U, Triantos C, Goulis J. Management of varices in cirrhosis. Expert Opin Pharmacother. 2011;12:721–735. doi: 10.1517/14656566.2011.537258. [DOI] [PubMed] [Google Scholar]
  • 17.Kiyosue H, Mori H, Matsumoto S. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radio Graphics. 2003;23:911–920. doi: 10.1148/rg.234025044. [DOI] [PubMed] [Google Scholar]
  • 18.Kiyosue H, Mori H, Matsumoto S. Transcatheter obliteration of gastric varices. Part 2. Strategy and techniques based on hemodynamic features. Radio Graphics. 2003;23:921–937. doi: 10.1148/rg.234025135. [DOI] [PubMed] [Google Scholar]
  • 19.Romero-Castro R, Pellicer-Bautista FJ, Jimenez-Saenz M. EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases. Gastrointest Endosc. 2007;66:402–407. doi: 10.1016/j.gie.2007.03.008. [DOI] [PubMed] [Google Scholar]
  • 20.Binmoeller KF, Weilert F, Shah JN. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection. Gastrointest Endosc. 2011;74:1019–1025. doi: 10.1016/j.gie.2011.06.030. [DOI] [PubMed] [Google Scholar]
  • 21.Sarin SK, Lahoti D, Saxena SP. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–1349. doi: 10.1002/hep.1840160607. [DOI] [PubMed] [Google Scholar]
  • 22.Hashizume M, Kitano S, Yamaga H. Endoscopic classification of gastric varices. Gastrointest Endosc. 1990;36:276–280. doi: 10.1016/s0016-5107(90)71023-1. [DOI] [PubMed] [Google Scholar]
  • 23.Willmann JK, Bauerfeind P, Boehm T. Contrast-enhanced MR angiography for differentiation between perigastric and submucosal gastric fundal varices. Rofo. 2003;175:507–514. doi: 10.1055/s-2003-38440. [DOI] [PubMed] [Google Scholar]
  • 24.Gulati MS, Paul SB, Arora NK. Esophageal and gastric vasculature in children with extrahepatic portal hypertension: evaluation by intravenous CT portography. Clin Imaging. 2000;24:351–356. doi: 10.1016/s0899-7071(00)00228-x. [DOI] [PubMed] [Google Scholar]
  • 25.Chen TK, Wu CH, Lee CL. Endoscopic ultrasonography in the differential diagnosis of giant gastric folds. J Formos Med Assoc. 1999;98:261–264. [PubMed] [Google Scholar]
  • 26.Wong RC, Farooq FT, Chak A. Endoscopic Doppler US probe for the diagnosis of gastric varices (with videos) Gastrointest Endosc. 2007;65:491–496. doi: 10.1016/j.gie.2006.11.017. [DOI] [PubMed] [Google Scholar]
  • 27.Wiechowska-Kozlowska A, Raszeja-Wyszomirska J, Wasilewicz MP. Upper gastrointestinal endosonography in patients evaluated for liver transplantation. Transplant Proc. 2009;41:3082–3084. doi: 10.1016/j.transproceed.2009.07.095. [DOI] [PubMed] [Google Scholar]
  • 28.Wiechowska-Kozłowska A, Białek A, Raszeja-Wyszomirska J. Ligation of oesophageal varices may increase formation of “deep” gastric collaterals. Hepatogastroenterology. 2010;57:262–267. [PubMed] [Google Scholar]
  • 29.Kim T, Shijo H, Kokawa H. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25:307–312. doi: 10.1053/jhep.1997.v25.pm0009021939. [DOI] [PubMed] [Google Scholar]
  • 30.Sarin SK, Jain AK, Jain M. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97:1010–1015. doi: 10.1111/j.1572-0241.2002.05622.x. [DOI] [PubMed] [Google Scholar]
  • 31.Chikamori F, Kuniyoshi N, Shibuya S. Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices. Dig Surg. 2001;18:176–181. doi: 10.1159/000050126. [DOI] [PubMed] [Google Scholar]
  • 32.Watanabe K, Kimura K, Matsutani S. Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology. 1988;95:434–440. doi: 10.1016/0016-5085(88)90501-x. [DOI] [PubMed] [Google Scholar]
  • 33.Nguyen AJ, Baron TH, Burgart LJ. 2-Octyl-cyanoacrylate (Dermabond), a new glue for variceal injection therapy: results of a preliminary animal study. Gastrointest Endosc. 2002;55:572–575. doi: 10.1067/mge.2002.122032. [DOI] [PubMed] [Google Scholar]
  • 34.Thakeb F, Salama Z, Salama H. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy. 1995;27:358–364. doi: 10.1055/s-2007-1005714. [DOI] [PubMed] [Google Scholar]
  • 35.Wang YM, Cheng LF, Li N. Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding. World J Gastroenterol. 2009;15:4945–4951. doi: 10.3748/wjg.15.4945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rodríguez ASM, Arias RB, Rodríguez RB. N-butyl-2-cyanoacrylate plug on fundal varix: persistence 3 years after sclerosis. Rev Esp Enferm Dig (Madrid) 2009;101:212–214. doi: 10.4321/s1130-01082009000300008. [DOI] [PubMed] [Google Scholar]
  • 37.Ramond MJ, Valla D, Mosnier JF. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology. 1989;10:488–493. doi: 10.1002/hep.1840100415. [DOI] [PubMed] [Google Scholar]
  • 38.Oho K, Iwao T, Sumino M, Toyonaga A. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy. 1995;27:349–354. doi: 10.1055/s-2007-1005712. [DOI] [PubMed] [Google Scholar]
  • 39.D'Imperio N, Piemontese A, Baroncini D. Evaluation of undiluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastro-intestinal tract varices. Endoscopy. 1996;28:239–243. doi: 10.1055/s-2007-1005435. [DOI] [PubMed] [Google Scholar]
  • 40.Miyazaki S, Yoshida T, Harada T. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Hepatogastroenterology. 1998;45:1155–1158. [PubMed] [Google Scholar]
  • 41.Ogawa K, Ishikawa S, Naritaka Y. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol. 1999;14:245–250. doi: 10.1046/j.1440-1746.1999.01842.x. [DOI] [PubMed] [Google Scholar]
  • 42.Kind R, Guglielmi A, Rodella L. Bucrylate treatment of bleeding gastric varices: 12 years experience. Endoscopy. 2000;32:512–519. doi: 10.1055/s-2000-3817. [DOI] [PubMed] [Google Scholar]
  • 43.Lee YT, Chan FK, Ng EK. EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc. 2000;52:168–174. doi: 10.1067/mge.2000.107911. [DOI] [PubMed] [Google Scholar]
  • 44.Huang YH, Yeh HZ, Chen GH. Endoscopic treatment for bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52:160–167. doi: 10.1067/mge.2000.104976. [DOI] [PubMed] [Google Scholar]
  • 45.Iwase H, Maeda O, Shimada M. Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointest Endosc. 2001;53:585–592. doi: 10.1067/mge.2001.113921. [DOI] [PubMed] [Google Scholar]
  • 46.Akahoshi T, Hashizume M, Shimabukuro R. Long-term results of endoscopic histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery. 2002;131(1 Suppl):S176–S181. doi: 10.1067/msy.2002.119501. [DOI] [PubMed] [Google Scholar]
  • 47.Lo GH, Lai KH, Cheng JS. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33:1060–1064. doi: 10.1053/jhep.2001.24116. [DOI] [PubMed] [Google Scholar]
  • 48.Dhiman RK, Chawla Y, Taneja S. Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol. 2002;35:222–227. doi: 10.1097/00004836-200209000-00005. [DOI] [PubMed] [Google Scholar]
  • 49.Sarin SK, Jain AK, Jain M. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97:1010–1015. doi: 10.1111/j.1572-0241.2002.05622.x. [DOI] [PubMed] [Google Scholar]
  • 50.Greenwald BD, Caldwell SH, Hespenheide EE. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol. 2003;98:1982–1988. doi: 10.1111/j.1572-0241.2003.07637.x. [DOI] [PubMed] [Google Scholar]
  • 51.Noophun P, Kongkam P, Gonlachanvit S. Bleeding gastric varices: results of endoscopic injection with cyanoacrylate at King Chulalongkorn Memorial Hospital. World J Gastroenterol. 2005;11:7531–7535. doi: 10.3748/wjg.v11.i47.7531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kim JW, Baik SK, Kim KH. Effect of endoscopic sclerotherapy using N-butyl-2-cyanoacrylate in patients with gastric variceal bleeding. Korean J Hepatol. 2006;12:394–403. [PubMed] [Google Scholar]
  • 53.Cheng LF, Wang ZQ, Li CZ. Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years' experience of 635 cases. Chinese Med J. 2007;120:2081–2085. [PubMed] [Google Scholar]
  • 54.Joo HS, Jang JY, Eun SH. Long-term results of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices-a 10-year experience. Korean J Gastroenterol. 2007;49:320–326. [PubMed] [Google Scholar]
  • 55.Mumtaz K, Majid S, Shah H. Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. World J Gastroenterol. 2007;13:1247–1251. doi: 10.3748/wjg.v13.i8.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Belletrutti PJ, Romagnuolo J, Hilsden RJ. Endoscopic management of gastric varices: Efficacy and outcomes of gluing with N-butyl-2-cyanoacrylate in a North American patient population. Can J Gastroenterol. 2008;22:931–936. doi: 10.1155/2008/389517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Seewald S, Ang TL, Imazu H. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos) Gastrointest Endosc. 2008;68:447–454. doi: 10.1016/j.gie.2008.02.050. [DOI] [PubMed] [Google Scholar]
  • 58.Fry LC, Neumann H, Olano C. Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices. Dig Dis. 2008;26:300–303. doi: 10.1159/000177012. [DOI] [PubMed] [Google Scholar]
  • 59.Marques P, Maluf-Filho F, Kumar A. Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci. 2008;53:544–550. doi: 10.1007/s10620-007-9882-5. [DOI] [PubMed] [Google Scholar]
  • 60.Martins FJ, de Macedo EP, de Paulo GA. Endoscopic follow-up of cyanoacrylate obliteration of gastric varices. Arq Gastroenterol. 2009;49:81–84. doi: 10.1590/s0004-28032009000100020. [DOI] [PubMed] [Google Scholar]
  • 61.Kumar A, Singh S, Madan K. Undiluted N-butyl cyanoacrylate is safe and effective for gastric variceal bleeding. Gastrointest Endosc. 2010;72:721–727. doi: 10.1016/j.gie.2010.06.015. [DOI] [PubMed] [Google Scholar]
  • 62.Al-Ali J, Pawlowska M, Coss A, Svarta S, Byrne M, Enns R. Endoscopic management of gastric variceal bleeding with cyanoacrylate glue injection: safety and efficacy in a Canadian population. Can J Gastroenterol. 2010;24:593–596. doi: 10.1155/2010/276273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sato T, Yamazaki K. Evaluation of therapeutic effects and serious complications following endoscopic obliterative therapy with histoacryl. Clin Exp Gastroenterol. 2010;3:91–95. doi: 10.2147/ceg.s12189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Choudhuri G, Chetri K, Bhat G. Long-term efficacy and safety of N-butylcyanoacrylate in endoscopic treatment of gastric varices. Trop Gastroenterol. 2010;31:155–164. [PubMed] [Google Scholar]
  • 65.Rajoriya N, Forrest EH, Gray J. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM. 2011;104:41–47. doi: 10.1093/qjmed/hcq161. [DOI] [PubMed] [Google Scholar]
  • 66.Kang EJ, Jeong SW, Jang JY. Long-term results of endoscopic Histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol. 2011;17:1494–1500. doi: 10.3748/wjg.v17.i11.1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Maluf-Filho F, Sakai P, Ishioka S. Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: a prospective, controlled and randomized study in Child-Pugh class C patients. Endoscopy. 2001;33:421–427. doi: 10.1055/s-2001-14257. [DOI] [PubMed] [Google Scholar]
  • 68.Tan PC, Hou MC, Lin HC. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43:690–697. doi: 10.1002/hep.21145. [DOI] [PubMed] [Google Scholar]
  • 69.Kurokohchi K, Maeta T, Ohgi T. Successful treatment of a giant exposed blood vessel in a gastric ulcer by endoscopic sclerotherapy with N-butyl-2-cyanoacrylate. Endoscopy. 2007;39(Suppl 1):E250. doi: 10.1055/s-2007-967012. [DOI] [PubMed] [Google Scholar]
  • 70.Kim EK, Sohn JH, Kim TY. Esophageal sinus formation due to cyanoacrylate injection for esophageal variceal ligation-induced ulcer bleeding in a cirrhotic patient. Korean J Gastroenterol. 2011;57:180–183. doi: 10.4166/kjg.2011.57.3.180. [DOI] [PubMed] [Google Scholar]
  • 71.Hou MC, Lin HC, Liu TT. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746–753. doi: 10.1002/hep.20126. [DOI] [PubMed] [Google Scholar]
  • 72.Jun CH, Park CH, Lee WS. Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study. J Korean Med Sci. 2006;21:883–890. doi: 10.3346/jkms.2006.21.5.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Wahl F, Lammer D, Cponen R. Septic complications after injection of N-butyl-2-cyanoacrylate: report of two cases and review. Gastrointest Endosc. 2004;59:911–916. doi: 10.1016/s0016-5107(04)00341-4. [DOI] [PubMed] [Google Scholar]
  • 74.Chen WC, Hou MC, Lin HC. Bacteraemia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric variceal bleeding. Gastrointest Endosc. 2001;54:214–218. doi: 10.1067/mge.2001.116566. [DOI] [PubMed] [Google Scholar]
  • 75.Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet. 1999;353:139–142. doi: 10.1016/S0140-6736(98)06020-6. [DOI] [PubMed] [Google Scholar]
  • 76.Liao SC, Ko CW, Yeh HZ. Successful treatment of persistent bacteremia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric varices bleeding. Endoscopy. 2007;39(Suppl 1):E176–E177. doi: 10.1055/s-2007-966556. [DOI] [PubMed] [Google Scholar]
  • 77.Galperine T, Flateau C, Venon MD, et al. Recurrent bacteremia, a complication of cyanoacrylate injection for variceal bleeding: report of two cases and review of the literature. Case Reports in Medicine Vol. 2009, Article ID 407053, 3 pages; doi:10.1155/2009/407053. [DOI] [PMC free article] [PubMed]
  • 78.Chang CJ, Shiau YT, Chen TL. Pyogenic portal vein thrombosis as a reservoir of persistent septicemia after cyanoacrylate injection for bleeding gastric varices. Digestion. 2008;78:139–143. doi: 10.1159/000175360. [DOI] [PubMed] [Google Scholar]
  • 79.Lee BY, Jang JY, Jeong SW. Two cases of adrenal abscesses following Histoacryl (N-butyl-2-cyanocrylate) injection. Gut Liver. 2011;5:242–244. doi: 10.5009/gnl.2011.5.2.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Sato T, Yamazaki K, Toyota J. Inflammatory tumor in pancreatic tail induced by endoscopic ablation with cyanoacrylate glue for gastric varices. J Gastroenterol. 2004;39:475–478. doi: 10.1007/s00535-003-1318-1. [DOI] [PubMed] [Google Scholar]
  • 81.Hamad N, Stephens J, Maskell GF. Thromboembolic and septic complications of migrated cyanoacrylate injected for bleeding gastric varices. Br J Radiol. 2008;81:e263–e265. doi: 10.1259/bjr/30231294. [DOI] [PubMed] [Google Scholar]
  • 82.ASGE Standards of Practice Committee, Banerjee S, Shen B, Baron TH. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–798. doi: 10.1016/j.gie.2008.02.068. [DOI] [PubMed] [Google Scholar]
  • 83.Takasugi JE, Shaw C. Inadvertent bucrylate pulmonary embolization: a case report. J Thorac Imaging. 1989;4:71–73. doi: 10.1097/00005382-198910000-00015. [DOI] [PubMed] [Google Scholar]
  • 84.Rickman OB, Utz JP, Aughenbaugh GL. Pulmonary embolization of 2-octyl cyanoacrylate after endoscopic injection therapy for gastric variceal bleeding. Mayo Clin Proc. 2004;79:1455–1458. doi: 10.4065/79.11.1455. [DOI] [PubMed] [Google Scholar]
  • 85.Hwang SS, Kim HH, Park SH. N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr. 2001;25:16–22. doi: 10.1097/00004728-200101000-00003. [DOI] [PubMed] [Google Scholar]
  • 86.Marion-Audibert AM, Schoeffler M, Wallet F. Acute fatal pulmonary embolism during cyanoacrylate injection in gastric varices. Gastroenterol Clin Biol. 2008;32:926–930. doi: 10.1016/j.gcb.2008.07.009. [DOI] [PubMed] [Google Scholar]
  • 87.Ashraf P, Haqqi SA, Shaikh H. Glue embolism: a rare cause of pulmonary embolism. J Coll Physician Surg Pak. 2011;21:574–576. [PubMed] [Google Scholar]
  • 88.Amouroux C, Cervoni JP, Delabrousse E. Portal vein thrombosis after cyanoacrylate injection therapy in bleeding gastric varices. Gastroenterol Clin Biol. 2009;33:205–207. doi: 10.1016/j.gcb.2009.01.006. [DOI] [PubMed] [Google Scholar]
  • 89.Roesch W, Rexroth G. Pulmonary, cerebral and coronary embolization during bucrylate injection of bleeding fundic varices. Endoscopy. 1998;30:S89–S90. doi: 10.1055/s-2007-1001406. [DOI] [PubMed] [Google Scholar]
  • 90.Turler A, Wolff M, Dorlars D. Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate. Gastrointest Endosc. 2001;53:228–230. doi: 10.1067/mge.2001.111561. [DOI] [PubMed] [Google Scholar]
  • 91.Seewald S, Sriram PV, Naga M. Cyanoacrylate glue in gastric variceal bleeding. Endoscopy. 2002;34:926–932. doi: 10.1055/s-2002-35312. [DOI] [PubMed] [Google Scholar]
  • 92.Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med. 1974;291:646–649. doi: 10.1056/NEJM197409262911303. [DOI] [PubMed] [Google Scholar]
  • 93.Ninoi T, Nakamura K, Kaminou T. TIPS versus transcatheter sclerotherapy for gastric varices. Am J Roentgenol. 2004;183:369–376. doi: 10.2214/ajr.183.2.1830369. [DOI] [PubMed] [Google Scholar]
  • 94.Stanley AJ, Hayes PC. Portal hypertension and variceal haemorrhage. Lancet. 1997;350:1235–1239. doi: 10.1016/S0140-6736(97)06283-1. [DOI] [PubMed] [Google Scholar]
  • 95.Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterology, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126:1175–1189. doi: 10.1053/j.gastro.2004.01.058. [DOI] [PubMed] [Google Scholar]
  • 96.Chikamori F, Kuniyoshi N, Kawashima T. Percutaneous transhepatic obliteration for isolated gastric varices with gastropericardiac shunt: case report. Abdom Imaging. 2006;31:249–252. doi: 10.1007/s00261-005-0372-y. [DOI] [PubMed] [Google Scholar]
  • 97.Chau TN, Patch D, Chan YW. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998;114:981–987. doi: 10.1016/s0016-5085(98)00640-4. [DOI] [PubMed] [Google Scholar]
  • 98.Tripathi D, Therapondos G, Jackson E. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002;51:270–274. doi: 10.1136/gut.51.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Lo GH, Liang HL, Chen WC. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679–685. doi: 10.1055/s-2007-966591. [DOI] [PubMed] [Google Scholar]
  • 100.Procaccini NJ, Al-Osaimi AM, Northup P. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center US analysis. Gastrointest Endosc. 2009;70:881–887. doi: 10.1016/j.gie.2009.03.1169. [DOI] [PubMed] [Google Scholar]
  • 101.Sanyal AJ, Freedman AM, Luketic VA. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112:889–898. doi: 10.1053/gast.1997.v112.pm9041251. [DOI] [PubMed] [Google Scholar]
  • 102.Somberg KA. TIPS: safe, effective, better? Am J Gastroenterol. 1997;92:1412–1416. [PubMed] [Google Scholar]
  • 103.Urata J, Yamashita Y, Hatanaka Y. Transjugular intrahepatic portosystemic shunt: initial clinical experience and three-year follow-up. Radiat Med. 1997;15:341–351. [PubMed] [Google Scholar]
  • 104.Chikamori F, Shibuya S, Takase Y. Transjugular retrograde obliteration for gastric varices. Abdom Imaging. 1996;21:299–303. doi: 10.1007/s002619900068. [DOI] [PubMed] [Google Scholar]
  • 105.Kanagawa H, Mima S, Kouyama H. Treatment of gastric fundal varices by balloon-occluded retrograde obliteration. Gastroenterol Hepatol. 1996;11:51–58. doi: 10.1111/j.1440-1746.1996.tb00010.x. [DOI] [PubMed] [Google Scholar]
  • 106.Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–336. doi: 10.1016/s1051-0443(07)61912-5. [DOI] [PubMed] [Google Scholar]
  • 107.Takuma Y, Nouso K, Makino Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2005;3:1245–1252. doi: 10.1016/s1542-3565(05)00744-5. [DOI] [PubMed] [Google Scholar]
  • 108.Chikamori F, Kuniyoshi N, Shibuya S. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism. Hepatogastroenterology. 2007;54:1847–1849. [PubMed] [Google Scholar]
  • 109.Chikamori F, Kuniyoshi N, Kawashima T. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. Am J Roentgenol. 2008;191:555–559. doi: 10.2214/AJR.07.3356. [DOI] [PubMed] [Google Scholar]
  • 110.Kameda N, Higuchi K, Shiba M. Management of gastric fundal varices without gastro-renal shunt in 15 patients. World J Gastroenterol. 2008;14:448–453. doi: 10.3748/wjg.14.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Shiba M, Higuchi K, Nakamura K. Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial. Gastrointest Endosc. 2002;56:522–528. doi: 10.1067/mge.2002.127410. [DOI] [PubMed] [Google Scholar]
  • 112.Binmoeller KF. Glue for gastric varices: some sticky issues. Gastrointest Endosc. 2000;52:298–301. doi: 10.1067/mge.2000.108042. [DOI] [PubMed] [Google Scholar]
  • 113.Hung HH, Chang CJ, Hou MC. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012 doi: 10.1016/j.jhep.2011.12.021. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Experimental Hepatology are provided here courtesy of Elsevier

RESOURCES